
Aemetis (AMTX) Stock Forecast & Price Target
Aemetis (AMTX) Analyst Ratings
Bulls say
Aemetis is positioned as a compelling turnaround story because fiscal Q3 2026 revenue rose to $88 million from $59 million a year earlier, while EPS of $(0.02) beat expectations and EBITDA improved to $25 million from $(5) million. The company’s expanding biogas platform, now at 14 digesters and 17 dairies with 40 miles of pipeline and over 50 dairies agreements, supports a credible path to higher recurring cash generation as project execution advances. Regulatory catalysts such as expanded E15 usage, CARB approval for dairy digester RNG pathways, and Section 45Z credits extended to 2029, combined with progress across its 4 main initiatives, underpin the bullish outlook despite liquidity risk.
Bears say
Aemetis is exposed to a fragile operating profile because its balance sheet and liquidity remain vulnerable, leaving limited room to absorb volatility in its renewable fuels and biochemicals businesses. Its performance is also highly dependent on political and regulatory support, alternative energy incentives, commodity and crude oil prices, and shifting consumer demand, all of which can quickly erode margins and cash generation. Competitive pressure, broader macroeconomic weakness, and negative investor sentiment toward energy and alternative energy stocks further increase execution risk across its North America and India segments.
This aggregate rating is based on analysts' research of Aemetis and is not a guaranteed prediction by Public.com or investment advice.
Aemetis (AMTX) Analyst Forecast & Price Prediction
Start investing in Aemetis (AMTX)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Aemetis (AMTX) Forecast
Aemetis (AMTX) Analyst Forecast & Price Prediction
Start investing in Aemetis (AMTX)
Order type
Buy in
Order amount
Est. shares
0 shares